{"entity":{"type":"insider","cik":"0001614740","url":"/insider/0001614740","json_url":"/insider/0001614740.json","name":"Peetz Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":24,"first":"2019-09-10","last":"2026-08-11","span_basis":"filed_date"},"name_variants":[{"name":"Peetz Christopher","source":"filing","n_filings":24,"first_seen":"2019-09-10","last_seen":"2026-08-11"}],"transactions":[{"id":9293125,"accession":"0001614740-26-000012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001614740-26-000012","line_url":"/filing/0001614740-26-000012#line-3","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":100.14,"price_display":"100.14","price_state":"stated","total_value":230322.0,"total_display":"230,322.00","shares_owned_after":194309.0,"shares_owned_after_display":"194,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-11","scope":"insider"},{"id":9293124,"accession":"0001614740-26-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001614740-26-000012","line_url":"/filing/0001614740-26-000012#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6017.0,"shares_display":"6,017","price_per_share":99.25,"price_display":"99.25","price_state":"stated","total_value":597187.25,"total_display":"597,187.25","shares_owned_after":196609.0,"shares_owned_after_display":"196,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-11","scope":"insider"},{"id":9293123,"accession":"0001614740-26-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001614740-26-000012","line_url":"/filing/0001614740-26-000012#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11683.0,"shares_display":"11,683","price_per_share":98.51,"price_display":"98.51","price_state":"stated","total_value":1150892.33,"total_display":"1,150,892.33","shares_owned_after":202626.0,"shares_owned_after_display":"202,626","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-11","scope":"insider"},{"id":6055372,"accession":"0001614740-26-000011","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001614740-26-000011","line_url":"/filing/0001614740-26-000011#line-5","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12134.0,"shares_display":"12,134","price_per_share":121.65,"price_display":"121.65","price_state":"stated","total_value":1476101.1,"total_display":"1,476,101.10","shares_owned_after":202175.0,"shares_owned_after_display":"202,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider"},{"id":6055370,"accession":"0001614740-26-000011","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001614740-26-000011","line_url":"/filing/0001614740-26-000011#line-4","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4181.0,"shares_display":"4,181","price_per_share":122.34,"price_display":"122.34","price_state":"stated","total_value":511503.54,"total_display":"511,503.54","shares_owned_after":197994.0,"shares_owned_after_display":"197,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider"},{"id":6055368,"accession":"0001614740-26-000011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001614740-26-000011","line_url":"/filing/0001614740-26-000011#line-3","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1975.0,"shares_display":"1,975","price_per_share":123.74,"price_display":"123.74","price_state":"stated","total_value":244386.5,"total_display":"244,386.50","shares_owned_after":196019.0,"shares_owned_after_display":"196,019","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider"},{"id":6055365,"accession":"0001614740-26-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001614740-26-000011","line_url":"/filing/0001614740-26-000011#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1710.0,"shares_display":"1,710","price_per_share":124.79,"price_display":"124.79","price_state":"stated","total_value":213390.9,"total_display":"213,390.90","shares_owned_after":194309.0,"shares_owned_after_display":"194,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider"},{"id":5813978,"accession":"0001614740-26-000010","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001614740-26-000010","line_url":"/filing/0001614740-26-000010#line-7","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16595.0,"shares_display":"16,595","price_per_share":95.34,"price_display":"95.34","price_state":"stated","total_value":1582167.3,"total_display":"1,582,167.30","shares_owned_after":205112.0,"shares_owned_after_display":"205,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":5813977,"accession":"0001614740-26-000010","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001614740-26-000010","line_url":"/filing/0001614740-26-000010#line-6","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6926.0,"shares_display":"6,926","price_per_share":96.15,"price_display":"96.15","price_state":"stated","total_value":665934.9,"total_display":"665,934.90","shares_owned_after":198186.0,"shares_owned_after_display":"198,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":5813975,"accession":"0001614740-26-000010","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001614740-26-000010","line_url":"/filing/0001614740-26-000010#line-5","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2602.0,"shares_display":"2,602","price_per_share":94.64,"price_display":"94.64","price_state":"stated","total_value":246253.28,"total_display":"246,253.28","shares_owned_after":221707.0,"shares_owned_after_display":"221,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":5813974,"accession":"0001614740-26-000010","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001614740-26-000010","line_url":"/filing/0001614740-26-000010#line-4","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1973.0,"shares_display":"1,973","price_per_share":97.56,"price_display":"97.56","price_state":"stated","total_value":192485.88,"total_display":"192,485.88","shares_owned_after":196213.0,"shares_owned_after_display":"196,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":5813972,"accession":"0001614740-26-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001614740-26-000010","line_url":"/filing/0001614740-26-000010#line-3","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1021.0,"shares_display":"1,021","price_per_share":98.2,"price_display":"98.20","price_state":"stated","total_value":100262.2,"total_display":"100,262.20","shares_owned_after":195192.0,"shares_owned_after_display":"195,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":5813970,"accession":"0001614740-26-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001614740-26-000010","line_url":"/filing/0001614740-26-000010#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":883.0,"shares_display":"883","price_per_share":99.66,"price_display":"99.66","price_state":"stated","total_value":87999.78,"total_display":"87,999.78","shares_owned_after":194309.0,"shares_owned_after_display":"194,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":6108879,"accession":"0001614740-26-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001614740-26-000009","line_url":"/filing/0001614740-26-000009#line-3","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40985.0,"shares_display":"40,985","price_per_share":91.9779,"price_display":"91.98","price_state":"stated","total_value":3769714.2315,"total_display":"3,769,714.23","shares_owned_after":194309.0,"shares_owned_after_display":"194,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider"},{"id":5786837,"accession":"0001614740-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001614740-26-000007","line_url":"/filing/0001614740-26-000007#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9108.0,"shares_display":"9,108","price_per_share":103.3035,"price_display":"103.30","price_state":"stated","total_value":940888.278,"total_display":"940,888.28","shares_owned_after":160294.0,"shares_owned_after_display":"160,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-03","scope":"insider"},{"id":6055360,"accession":"0001614740-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001614740-26-000003","line_url":"/filing/0001614740-26-000003#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6831.0,"shares_display":"6,831","price_per_share":96.192,"price_display":"96.19","price_state":"stated","total_value":657087.552,"total_display":"657,087.55","shares_owned_after":169402.0,"shares_owned_after_display":"169,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-27","scope":"insider"},{"id":5801911,"accession":"0001614740-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001614740-26-000002","line_url":"/filing/0001614740-26-000002#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7098.0,"shares_display":"7,098","price_per_share":93.3252,"price_display":"93.33","price_state":"stated","total_value":662422.2696,"total_display":"662,422.27","shares_owned_after":163733.0,"shares_owned_after_display":"163,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":4358818,"accession":"0001415889-25-021521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-021521","line_url":"/filing/0001415889-25-021521#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":62.0,"price_display":"62.00","price_state":"stated","total_value":2480000.0,"total_display":"2,480,000.00","shares_owned_after":138641.0,"shares_owned_after_display":"138,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-12","scope":"insider"},{"id":4383395,"accession":"0001415889-25-021350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-021350","line_url":"/filing/0001415889-25-021350#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":55.251,"price_display":"55.25","price_state":"stated","total_value":2210040.0,"total_display":"2,210,040.00","shares_owned_after":138641.0,"shares_owned_after_display":"138,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-07","filed_date":"2025-08-08","scope":"insider"},{"id":4108454,"accession":"0001415889-25-008556","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-008556","line_url":"/filing/0001415889-25-008556#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27279.0,"shares_display":"27,279","price_per_share":44.2143,"price_display":"44.21","price_state":"stated","total_value":1206121.8897,"total_display":"1,206,121.89","shares_owned_after":138641.0,"shares_owned_after_display":"138,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-18","scope":"insider"},{"id":4589059,"accession":"0001415889-25-006524","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-006524","line_url":"/filing/0001415889-25-006524#line-3","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20608.0,"shares_display":"20,608","price_per_share":47.19,"price_display":"47.19","price_state":"stated","total_value":972491.52,"total_display":"972,491.52","shares_owned_after":115920.0,"shares_owned_after_display":"115,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":4589054,"accession":"0001415889-25-006524","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-006524","line_url":"/filing/0001415889-25-006524#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19392.0,"shares_display":"19,392","price_per_share":46.61,"price_display":"46.61","price_state":"stated","total_value":903861.12,"total_display":"903,861.12","shares_owned_after":136528.0,"shares_owned_after_display":"136,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":4357058,"accession":"0001415889-25-002981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-002981","line_url":"/filing/0001415889-25-002981#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9102.0,"shares_display":"9,102","price_per_share":48.2225,"price_display":"48.22","price_state":"stated","total_value":438921.195,"total_display":"438,921.20","shares_owned_after":115920.0,"shares_owned_after_display":"115,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":4432492,"accession":"0001415889-25-002134","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-002134","line_url":"/filing/0001415889-25-002134#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6837.0,"shares_display":"6,837","price_per_share":47.9243,"price_display":"47.92","price_state":"stated","total_value":327658.4391,"total_display":"327,658.44","shares_owned_after":125022.0,"shares_owned_after_display":"125,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-24","filed_date":"2025-01-27","scope":"insider"},{"id":4107676,"accession":"0001415889-25-001143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-001143","line_url":"/filing/0001415889-25-001143#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7489.0,"shares_display":"7,489","price_per_share":42.8153,"price_display":"42.82","price_state":"stated","total_value":320643.7817,"total_display":"320,643.78","shares_owned_after":119359.0,"shares_owned_after_display":"119,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-08","scope":"insider"},{"id":3234786,"accession":"0001415889-24-002754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-002754","line_url":"/filing/0001415889-24-002754#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6013.0,"shares_display":"6,013","price_per_share":26.1918,"price_display":"26.19","price_state":"stated","total_value":157491.2934,"total_display":"157,491.29","shares_owned_after":104112.0,"shares_owned_after_display":"104,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-05","scope":"insider"},{"id":2658865,"accession":"0001415889-24-000881","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-000881","line_url":"/filing/0001415889-24-000881#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5209.0,"shares_display":"5,209","price_per_share":28.0348,"price_display":"28.03","price_state":"stated","total_value":146033.2732,"total_display":"146,033.27","shares_owned_after":110125.0,"shares_owned_after_display":"110,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":7870750,"accession":"0001209191-23-041330","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041330","line_url":"/filing/0001209191-23-041330#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5498.0,"shares_display":"5,498","price_per_share":25.6466,"price_display":"25.65","price_state":"stated","total_value":141005.0068,"total_display":"141,005.01","shares_owned_after":115334.0,"shares_owned_after_display":"115,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-05","scope":"insider"},{"id":2928675,"accession":"0001415889-24-008313","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-008313","line_url":"/filing/0001415889-24-008313#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5159.0,"shares_display":"5,159","price_per_share":20.6223,"price_display":"20.62","price_state":"stated","total_value":106390.4457,"total_display":"106,390.45","shares_owned_after":91953.0,"shares_owned_after_display":"91,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2024-03-18","scope":"insider"},{"id":5437819,"accession":"0001209191-21-067067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-067067","line_url":"/filing/0001209191-21-067067#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":14.4,"price_display":"14.40","price_state":"stated","total_value":100800.0,"total_display":"100,800.00","shares_owned_after":28027.0,"shares_owned_after_display":"28,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-29","scope":"insider"},{"id":4343355,"accession":"0001209191-21-058610","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-058610","line_url":"/filing/0001209191-21-058610#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3672.0,"shares_display":"3,672","price_per_share":19.256,"price_display":"19.26","price_state":"stated","total_value":70708.032,"total_display":"70,708.03","shares_owned_after":21027.0,"shares_owned_after_display":"21,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-01","scope":"insider"},{"id":9293300,"accession":"0001626199-21-000131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626199-21-000131","line_url":"/filing/0001626199-21-000131#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":10.17,"price_display":"10.17","price_state":"stated","total_value":19323.0,"total_display":"19,323.00","shares_owned_after":1900.0,"shares_owned_after_display":"1,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-23","filed_date":"2021-09-27","scope":"insider"},{"id":4799128,"accession":"0001626199-21-000126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626199-21-000126","line_url":"/filing/0001626199-21-000126#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":10.17,"price_display":"10.17","price_state":"stated","total_value":19323.0,"total_display":"19,323.00","shares_owned_after":1900.0,"shares_owned_after_display":"1,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-23","filed_date":"2021-09-24","scope":"insider"},{"id":2193840,"accession":"0001209191-20-065165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-065165","line_url":"/filing/0001209191-20-065165#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":18.76,"price_display":"18.76","price_state":"stated","total_value":56280.0,"total_display":"56,280.00","shares_owned_after":199570.0,"shares_owned_after_display":"199,570","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2020-12-28","scope":"insider"},{"id":2193836,"accession":"0001209191-20-065165","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-065165","line_url":"/filing/0001209191-20-065165#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":18.6,"price_display":"18.60","price_state":"stated","total_value":37200.0,"total_display":"37,200.00","shares_owned_after":201570.0,"shares_owned_after_display":"201,570","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2020-12-28","scope":"insider"},{"id":7841930,"accession":"0001209191-19-049090","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-049090","line_url":"/filing/0001209191-19-049090#line-3","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2320.0,"shares_display":"2,320","price_per_share":11.35,"price_display":"11.35","price_state":"stated","total_value":26332.0,"total_display":"26,332.00","shares_owned_after":196570.0,"shares_owned_after_display":"196,570","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-10","scope":"insider"},{"id":7841927,"accession":"0001209191-19-049090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049090","line_url":"/filing/0001209191-19-049090#line-2","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":10.9,"price_display":"10.90","price_state":"stated","total_value":21800.0,"total_display":"21,800.00","shares_owned_after":194250.0,"shares_owned_after_display":"194,250","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-10","scope":"insider"},{"id":7841924,"accession":"0001209191-19-049090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049090","line_url":"/filing/0001209191-19-049090#line-1","is_derivative":false,"issuer_cik":"0001614740","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001614740","owner_cik":"0001614740","owner_name":"Peetz Christopher","owner_url":"/insider/0001614740","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4750.0,"shares_display":"4,750","price_per_share":10.9065,"price_display":"10.91","price_state":"stated","total_value":51805.875,"total_display":"51,805.88","shares_owned_after":192250.0,"shares_owned_after_display":"192,250","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-06","filed_date":"2019-09-10","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":38,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":38},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001759425","name":"Mirum Pharmaceuticals, Inc.","url":"/issuer/0001759425","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":22,"first_seen":"2019-09-10","last_seen":"2026-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001626199","name":"ALPINE IMMUNE SCIENCES, INC.","url":"/issuer/0001626199","role":"Director","n_filings":2,"first_seen":"2021-09-24","last_seen":"2021-09-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001614740","retrieved_at":"2026-08-21T13:58:58+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}